Observed Signal · Oct 2, 2026 · Policy Update · Source: Astral Codex Ten · Impact: 1/5 · Sentiment: Positive
Couple uses AI to detect missed fibroid, conceive
In a guest post on Astral Codex Ten, Drew Housman recounts how he and his wife, after six years of unexplained infertility, used ChatGPT as a diagnostic aid. By prompting GPT-4 to role-play a doctor ("Dr. Reid") and asking detailed medical questions, they discovered a previously undetected 6 cm submucosal fibroid that likely impeded embryo implantation. After having it removed, his wife conceived naturally. The story highlights the potential of LLMs in providing accessible, thorough medical analysis, despite occasional errors and safety restrictions, and underscores the value of AI as a complementary tool for patients navigating complex healthcare systems.
Personal anecdote on LLM use in healthcare; low relevance to AdTech/MarTech industry.
Track OpenAI Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- 6 cm submucosal fibroid was detected via MRI after ChatGPT suggested the scan.
- The fibroid was missed during 6 years of fertility treatments.
- After laparoscopic myomectomy, the wife conceived naturally.
- ChatGPT was used for medical Q&A, with answers spot-checked by human doctors.
- The story was published as a guest post on Oct 2, 2026, on Astral Codex Ten.
Connected Companies & Entities
1 Entity mapped“The author uses ChatGPT (by OpenAI) as an AI doctor, noting 'Once GPT-4 came out'....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
OpenAI Launches ChatGPT Health Section
OpenAI has launched ChatGPT Health, a dedicated health area inside ChatGPT that connects medical records and consumer health apps such as Apple Health, MyFitnessPal, Weight Watchers, and Function. The feature enables users to upload documents and access health data within a private, encrypted space, and OpenAI says data will not be used to train the base models. ChatGPT Health aims to help users understand lab results, answer health questions, and prepare for doctor visits, while explicitly not diagnosing or replacing clinicians. The development involved input from over 260 physicians across 60 countries to ensure safe, clear, and contextually appropriate responses, including guidance on when professional medical advice is necessary. It starts with a small tester group and will roll out to Web and iOS in coming weeks, with the new area appearing in the ChatGPT sidebar when available. OpenAI is partnering with b.well for US EHR connections; Apple Health integration requires an iOS device.
Researcher Tricks Chatbots with Fake Eye Disease
A Swedish researcher, Almira Osmanovic Lindström of the University of Gothenburg, created a fabricated eye disease called "Bixonimanie" and intentionally seeded fake blog posts and preprint studies online to show how AI systems acquire and can be influenced in their knowledge. Major conversational AI systems — Microsoft Copilot, Perplexity AI and OpenAI's ChatGPT — subsequently produced hallucinated warnings and diagnostic suggestions about the nonexistent disease. Nature reported the experiment and its results; the Medium posts and preprints were removed after publication, and a Cureus paper (published November 2024) that cited the fake material was retracted at the end of March 2026. Experts warned the case demonstrates how misinformation can propagate into LLM outputs and even be cited in other research.
Author Combines GLP‑1 Drug With AI Health Chatbots
The author describes a personal experiment pairing weekly injections of tirzepatide (Zepbound) with AI-driven analysis from Claude and ChatGPT after those chatbots launched Apple Health integrations that let them ingest health data. The piece reports broad GLP‑1 adoption—nearly 1 in 5 U.S. adults have used a GLP‑1 drug and 12% are currently taking one—and explains tirzepatide’s mechanism as a dual GLP‑1/GIP agonist linked to large average weight loss in trials. The author reports improved hunger control, longer focused work sessions (tracked via RescueTime), and practical value from AI synthesizing workouts, nutrition, and bloodwork. The essay argues the combination of pharmaceutical appetite control and conversational AI access to consolidated health data could reshape consumer expectations for platforms like Apple and alter how health and attention are managed by technology.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.